Begin main content

Reports

We found 6402 result(s)

glucagon (TBC)

Last Updated: June 25, 2019
Result type: Reports
Product Line: Common Drug Review
Generic Name: glucagon
Indications: Severe hypoglycemic reactions

  • Brand Name: TBC
  • Manufacturer: Eli Lilly Canada Inc.
  • Project Number: SR0626-000
  • Project Status: Pending
  • Submission Type: New

esketamine hydrochloride (TBC )

Last Updated: June 25, 2019
Result type: Reports
Product Line: Common Drug Review
Generic Name: esketamine hydrochloride
Indications: Major depressive disorder (MDD), adults

  • Brand Name: TBC
  • Manufacturer: Janssen Inc.
  • Project Number: SR0621-000
  • Project Status: Received
  • Submission Type: New

Call for Patient Input and Clinical Experts: glucagon

Published on: June 25, 2019
Result type: News

CADTH has received the following notice(s) of pending drug submission(s). Brand name TBC Generic name glucagon Manufacturer Eli Lilly Canada Inc. Indication(s) Severe hypoglycemic reactions Project Number SR0626-000 Call for patient input 2019-06-25 Patient input d...

risankizumab (Skyrizi)

Last Updated: June 24, 2019
Result type: Reports
Product Line: Common Drug Review
Generic Name: risankizumab
Indications: Psoriasis, moderate to severe plaque

  • Brand Name: Skyrizi
  • Manufacturer: AbbVie Corporation
  • Project Number: SR0583-000
  • Project Status: Complete
  • Submission Type: New

Latanoprostene bunod (Vyzulta )

Last Updated: June 24, 2019
Result type: Reports
Product Line: Common Drug Review
Generic Name: latanoprostene bunod
Indications: Open-angle glaucoma or ocular hypertension

  • Brand Name: Vyzulta
  • Manufacturer: Bausch Health, Canada Inc.
  • Project Number: SR0590-000
  • Project Status: Active
  • Submission Type: New

patisiran (Onpattro)

Last Updated: June 24, 2019
Result type: Reports
Product Line: Common Drug Review
Generic Name: patisiran
Indications: Polyneuropathy in hereditary transthyretin-mediated amyloidosis

  • Brand Name: Onpattro
  • Manufacturer: Alnylam Netherlands BV
  • Project Number: SR0598-000
  • Project Status: Active
  • Submission Type: New

glycopyrrolate (Cuvposa)

Last Updated: June 24, 2019
Result type: Reports
Product Line: Common Drug Review
Generic Name: glycopyrrolate
Indications: chronic severe drooling, neurologic (pediatric)

  • Brand Name: Cuvposa
  • Manufacturer: MEDEXUS Pharmaceuticals, Inc.
  • Project Number: SR0613-000
  • Project Status: Active
  • Submission Type: New